Efficacy of high versus conventional dose of ergocalciferol supplementation on serum 25-hydroxyvitamin D and interleukin-6 levels among hemodialysis patients with vitamin D deficiency: A multicenter, randomized, controlled study.

Published on Aug 17, 2021in Therapeutic Apheresis and Dialysis1.041
· DOI :10.1111/1744-9987.13722
Naowanit Nata5
Estimated H-index: 5
,
Wittaya Siricheepchaiyan + 1 AuthorsBancha Satirapoj15
Estimated H-index: 15
Sources
Abstract
Long-term dialysis involves a chronic inflammatory state and produces a high prevalence of vitamin D deficiency. A clinical trial was conducted in hemodialysis with serum 25-hydroxyvitamin D (25[OH]D) level <30 ng/ml. The conventional-group (N = 35) and the high-dose group (N = 35) were treated with ergocalciferol according to the K/DOQI guidelines and double dosage of ergocalciferol from the recommendation for 8 weeks, respectively. The main outcomes were measured by serum 25[OH]D and interleukin-6 (IL-6). At the end of 8 weeks, a statistically significant greater increase was observed of mean serum 25[OH]D levels and a decrease of mean parathyroid hormone levels in the high-dose group compared with the conventional-dose group. The high dose group had the higher achievement of vitamin D sufficiency than the conventional-dose group (97.4% vs. 76.4%, p = 0.012). No significant difference was found in mean changes of serum IL-6 level in both groups, except subgroup patients with vitamin D deficiency or serum 25[OH]D <20 ng/ml, high dose treatment suppressed serum IL-6 level (-2.67 pg/ml [IQR -6.56 to -0.17], p = 0.039). No differences were observed between the two groups in adverse events. Oral high-dose ergocalciferol supplementation has achieved higher vitamin D sufficiency than standard dose in end stage renal disease patients on dialysis.
📖 Papers frequently viewed together
9 Citations
4 Citations
2 Citations
References29
Newest
#1Jordan Zuvela (Flinders University)H-Index: 1
#2Claire Trimingham (Royal Adelaide Hospital)H-Index: 2
Last. Anthony Meade (Flinders University)H-Index: 7
view all 7 authors...
AIM: The aim of the present study was to describe the prevalence of all gastrointestinal (GI) symptoms reported by dialysis patients, as well as the tools being used for diagnosis. GI symptoms are commonly reported in patients having haemodialysis (HD) and peritoneal dialysis (PD), but there are multiple definitions and assessment tools reported in the literature. METHODS: A comprehensive systematic review was undertaken using five databases (Embase, Medline, CINAHL, Psycinfo and Web of Science)...
26 CitationsSource
#1Guillaume JeanH-Index: 29
#2Jean-Claude Souberbielle (Necker-Enfants Malades Hospital)H-Index: 57
Last. Charles ChazotH-Index: 36
view all 3 authors...
Vitamin D deficiency (<20 ng/mL) and insufficiency (20–29 ng/mL) are common among patients with chronic kidney disease (CKD) or undergoing dialysis. In addition to nutritional and sunlight exposure deficits, factors that affect vitamin D deficiency include race, sex, age, obesity and impaired vitamin D synthesis and metabolism. Serum 1,25(OH)2D levels also decrease progressively because of 25(OH)D deficiency, together with impaired availability of 25(OH)D by renal proximal tubular cells, high fi...
102 CitationsSource
#1Marion Schneider Meireles (UNIFESP: Federal University of São Paulo)H-Index: 5
#2Maria Ayako Kamimura (UNIFESP: Federal University of São Paulo)H-Index: 26
Last. Lilian Cuppari (UNIFESP: Federal University of São Paulo)H-Index: 40
view all 6 authors...
Summary Background & aims Hypovitaminosis D and inflammation are highly prevalent among patients undergoing dialysis, and the association of both conditions with worse survival has been well recognized. Although a potential role for vitamin D in the immune system has been suggested, the effect of the treatment of hypovitaminosis D on the modulation of the inflammatory response remains unclear. The aim of this study was to investigate the effect of the restoration of the vitamin D status on the e...
22 CitationsSource
#1Jennifer L. Jackson (UAB: University of Alabama at Birmingham)H-Index: 1
#2Suzanne E. Judd (UAB: University of Alabama at Birmingham)H-Index: 63
Last. Orlando M. Gutiérrez (UAB: University of Alabama at Birmingham)H-Index: 52
view all 7 authors...
Abstract Aims Vitamin D is a fat-soluble vitamin classically known for its role in calcium absorption and bone health. Growing evidence indicates that vitamin D deficiency may be associated with inflammation, insulin resistance, and obesity. However, prior studies examining the association of vitamin D with metabolic risk factors had relatively low representation of individuals of black race, limiting their ability to characterize associations of vitamin D and parameters of metabolic health in b...
20 CitationsSource
#1Dana C. Miskulin (Tufts University)H-Index: 36
#2Karen Majchrzak (Dialysis Clinic, Inc)H-Index: 2
Last. Daniel E. Weiner (Tufts University)H-Index: 60
view all 7 authors...
Locally produced 1,25-dihydroxyvitamin D3 may have pleiotropic effects outside of bone. Experimental and observational studies suggest that nutritional vitamin D may enhance erythropoiesis in settings of 25-hydroxy vitamin D (25(OH)D) deficiency. We conducted a double-blind, placebo-controlled, randomized clinical trial to assess the effects of supplementation with ergocalciferol on epoetin utilization and other secondary outcomes in patients on hemodialysis with serum 25(OH)D P =0.78). No chang...
43 CitationsSource
#1Wen Chih Liu (TMU: Taipei Medical University)H-Index: 9
#2Chia-Chao Wu (NDMC: National Defense Medical Center)H-Index: 22
Last. Kun Chieh YehH-Index: 1
view all 8 authors...
Low 25(OH)D levels are common in chronic kidney disease (CKD) patients and are implicated in all-cause mortality and morbidity risks. Furthermore, the progression of CKD is accompanied by a gradual decline in 25(OH)D production. Vitamin D deficiency in CKD causes skeletal disorders, such as osteoblast or osteoclast cell defects, bone turnover imbalance, and deterioration of bone quality, and nonskeletal disorders, such as metabolic syndrome, hypertension, immune dysfunction, hyperlipidemia, diab...
29 CitationsSource
#1Wen Chih LiuH-Index: 9
#2Cai Mei Zheng (TMU: Taipei Medical University)H-Index: 12
Last. Kuo Cheng Lu (FJU: Fu Jen Catholic University)H-Index: 18
view all 7 authors...
The common causes of death in chronic kidney disease (CKD) patients are cardiovascular events and infectious disease. These patients are also predisposed to the development of vitamin D deficiency, which leads to an increased risk of immune dysfunction. Many extra-renal cells possess the capability to produce local active 1,25(OH)2D in an intracrine or paracrine fashion, even without kidney function. Vitamin D affects both the innate and adaptive immune systems. In innate immunity, vitamin D pro...
21 CitationsSource
#1Nan Zhu (SJTU: Shanghai Jiao Tong University)H-Index: 5
#2Jialin Wang (SJTU: Shanghai Jiao Tong University)H-Index: 2
Last. Weijie Yuan (SJTU: Shanghai Jiao Tong University)H-Index: 9
view all 5 authors...
AbstractChronic kidney disease (CKD) is a significant public health problem and Vitamin D deficiency is prevalent in CKD and might be associated with calcium and phosphate metabolism, cardiovascular disease, infections as well as the progress of kidney dysfunction. Emerging evidence implies that Vitamin D supplements may be of benefit to CKD. Based on existing laboratory and clinical evidence, this review intends to discuss the effectiveness of Vitamin D supplements and controversy in clinical p...
8 CitationsSource
Background : Vitamin D deficiency/insufficiency is common in chronic kidney disease (CKD) patients and it contributes to secondary hyperparathyroidism, which occurs early in CKD. It is not clear whether the Kidney Disease Outcomes Quality Initiative (K/DOQI) recommended doses of ergocalciferol are adequate for correction of vitamin D insufficiency and hyperparathyroidism. Objective : To evaluate the parathyroid hormone (PTH)-lowering effect, safety, and tolerability of high-dose ergocalciferol c...
10 Citations
Background and objectives Vitamin D (25-hydroxyvitamin D; 25[OH]D) deficiency is common in patients initiating long-term hemodialysis, but the safety and efficacy of nutritional vitamin D supplementation in this population remain uncertain. Design, setting, participants, & measurements This randomized, placebo-controlled, parallel-group multicenter trial compared two doses of ergocalciferol with placebo between October 2009 and March 2013. Hemodialysis patients ( n =105) with 25(OH)D levels ≤32 ...
56 CitationsSource
Cited By0
Newest